M2084735
Dolutegravirintermediate-1? , ≥99% , 1335210-23-5
| Pack Size | Price | Stock | Quantity |
| 1mg | RMB446.40 | In Stock |
|
| 5mg | RMB892.80 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Boiling point: | 474.1±45.0 °C(Predicted) |
| Density | 1.36±0.1 g/cm3(Predicted) |
| storage temp. | Inert atmosphere,Room Temperature |
| solubility | Chloroform, DMSO (Slightly), Methanol (Slightly) |
| pka | 5.56±0.40(Predicted) |
| form | Solid |
| color | White to Light Yellow |
Description and Uses
Dolutegravir intermediate-1 (1-(2,2-diMethoxyethyl)-5-Methoxy-6-(Methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid) is used as an intermediate in the synthesis of GSK1265744 (I), a potent HIV integrase inhibitor.
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P305+P351+P338 |
RELATED PRODUCTS
Bis(3,5-dibromosalicyl)fumarate
71337-53-6
71337-53-6
![(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid](https://img.chemicalbook.com/CAS/20180703/GIF/1616342-45-0.gif)
(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid
1616342-45-0
1616342-45-0
(2,4,6-Trifluorophenyl)methanamine
214759-21-4
214759-21-4
![(2R,5S,13aR)-8-methoxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide](https://img.chemicalbook.com/CAS/20180703/GIF/1616340-94-3.gif)
(2R,5S,13aR)-8-methoxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
1616340-94-3
1616340-94-3
N-(2-Chloropyrimidin-4-yl)-N,2,3-trimethyl-2H-indazol-6-amine
444731-75-3
444731-75-3